Regulatory News
Wednesday, September 21, 2016
AstraZeneca pulls cancer drug application in Europe
LONDON, Sept 21 (Reuters) - AstraZeneca has pulled
an application seeking European approval to sell its
experimental cancer drug cediranib in combination with
chemotherapy to treat ovarian cancer...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment